Novavax Covid Vaccine Gets First Authorization, "More Expected" Says CEO
NDTV
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its CEO Stanley Erck said after the shot received its first emergency use authorization (EUA) from Indonesia.
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.
Novavax shares were up about 13 per cent after the company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.
For Indonesia, the shot will be manufactured by the world's largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company's brand name, Covovax.
Novavax said initial shipments into Indonesia are expected to begin imminently.
